“In the coming weeks, we will present the results of our study among children aged five to eleven to authorities around the world and will apply for the approval of a vaccine for this age group, including here in Europe,” Türeci said.
According to Ugur Shahin, CEO and co-founder of BioNTech, the results of the study are already available and need to be processed for approval by the authorities.
He assured that the process of introducing this vaccine is going according to plan.
In addition, the results of a study in children aged six months and older are expected to be available by the end of the year.
Meanwhile, on the African continent, only 2% of the population has been vaccinated against coronavirus.
"Almost 75% ... of the doses received by residents of only 10 countries. Africa has the lowest vaccination coverage - only 2%. The head of the WHO stressed that this is absolutely unacceptable. He reiterated that it will be possible to overcome the Covid-19 pandemic only when at least 70 percent of the world's population is vaccinated," the statement said.